nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—REN—submandibular gland—salivary gland cancer	0.156	0.318	CbGeAlD
Captopril—LTA4H—parotid gland—salivary gland cancer	0.0191	0.0391	CbGeAlD
Captopril—LTA4H—saliva-secreting gland—salivary gland cancer	0.0183	0.0374	CbGeAlD
Captopril—REN—neck—salivary gland cancer	0.0181	0.0371	CbGeAlD
Captopril—LTA4H—connective tissue—salivary gland cancer	0.0168	0.0344	CbGeAlD
Captopril—MMP2—neck—salivary gland cancer	0.0167	0.0341	CbGeAlD
Captopril—MMP9—neck—salivary gland cancer	0.0145	0.0296	CbGeAlD
Captopril—REN—saliva-secreting gland—salivary gland cancer	0.0141	0.0289	CbGeAlD
Captopril—MMP2—parotid gland—salivary gland cancer	0.0136	0.0277	CbGeAlD
Captopril—MMP2—saliva-secreting gland—salivary gland cancer	0.013	0.0266	CbGeAlD
Captopril—REN—connective tissue—salivary gland cancer	0.013	0.0266	CbGeAlD
Captopril—F2—neck—salivary gland cancer	0.0126	0.0258	CbGeAlD
Captopril—REN—epithelium—salivary gland cancer	0.0123	0.0252	CbGeAlD
Captopril—LTA4H—lymphoid tissue—salivary gland cancer	0.0123	0.0252	CbGeAlD
Captopril—MMP2—connective tissue—salivary gland cancer	0.0119	0.0244	CbGeAlD
Captopril—MMP2—epithelium—salivary gland cancer	0.0113	0.0232	CbGeAlD
Captopril—MMP9—connective tissue—salivary gland cancer	0.0104	0.0212	CbGeAlD
Captopril—MMP9—epithelium—salivary gland cancer	0.00985	0.0202	CbGeAlD
Captopril—F2—connective tissue—salivary gland cancer	0.00906	0.0185	CbGeAlD
Captopril—MMP2—lymphoid tissue—salivary gland cancer	0.00873	0.0178	CbGeAlD
Captopril—F2—epithelium—salivary gland cancer	0.0086	0.0176	CbGeAlD
Captopril—ACE—neck—salivary gland cancer	0.00772	0.0158	CbGeAlD
Captopril—MMP9—lymphoid tissue—salivary gland cancer	0.00759	0.0155	CbGeAlD
Captopril—SLC15A1—epithelium—salivary gland cancer	0.00733	0.015	CbGeAlD
Captopril—LTA4H—lymph node—salivary gland cancer	0.00694	0.0142	CbGeAlD
Captopril—F2—lymphoid tissue—salivary gland cancer	0.00662	0.0135	CbGeAlD
Captopril—ACE—connective tissue—salivary gland cancer	0.00553	0.0113	CbGeAlD
Captopril—ACE—epithelium—salivary gland cancer	0.00525	0.0107	CbGeAlD
Captopril—MMP2—lymph node—salivary gland cancer	0.00492	0.0101	CbGeAlD
Captopril—MMP9—lymph node—salivary gland cancer	0.00428	0.00876	CbGeAlD
Captopril—ACE—lymphoid tissue—salivary gland cancer	0.00405	0.00827	CbGeAlD
Captopril—ALB—lymph node—salivary gland cancer	0.00238	0.00488	CbGeAlD
Captopril—ACE—lymph node—salivary gland cancer	0.00228	0.00467	CbGeAlD
Captopril—ABCB1—epithelium—salivary gland cancer	0.00185	0.00378	CbGeAlD
Captopril—MMP2—ATF-2 transcription factor network—EP300—salivary gland cancer	0.00171	0.00335	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—PIK3CA—salivary gland cancer	0.0017	0.00333	CbGpPWpGaD
Captopril—MMP9—IL1 and megakaryotyces in obesity—PIK3CA—salivary gland cancer	0.0017	0.00333	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—PIK3CA—salivary gland cancer	0.00169	0.00331	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PHGDH—salivary gland cancer	0.00165	0.00323	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF16—salivary gland cancer	0.00163	0.00319	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—IGFBP2—salivary gland cancer	0.00163	0.00319	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGFR4—salivary gland cancer	0.00163	0.00319	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—salivary gland cancer	0.00163	0.00319	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—GAS6—salivary gland cancer	0.00162	0.00316	CbGpPWpGaD
Captopril—F2—Hemostasis—JMJD1C—salivary gland cancer	0.00161	0.00316	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ST3GAL4—salivary gland cancer	0.00159	0.00311	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—HRAS—salivary gland cancer	0.00157	0.00306	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00156	0.00305	CbGpPWpGaD
Captopril—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00156	0.00305	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CNTN6—salivary gland cancer	0.00148	0.00289	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—salivary gland cancer	0.00146	0.00285	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—GAS6—salivary gland cancer	0.00145	0.00284	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—salivary gland cancer	0.00144	0.00283	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AQP1—salivary gland cancer	0.00144	0.00282	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00144	0.00281	CbGpPWpGaD
Captopril—ABCB1—lymphoid tissue—salivary gland cancer	0.00142	0.00291	CbGeAlD
Captopril—REN—Metabolism of proteins—FBXW7—salivary gland cancer	0.00139	0.00273	CbGpPWpGaD
Captopril—MMP9—Osteopontin-mediated events—PIK3CA—salivary gland cancer	0.00139	0.00272	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—ST3GAL4—salivary gland cancer	0.00135	0.00265	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FOXO3—salivary gland cancer	0.00135	0.00265	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—salivary gland cancer	0.00134	0.00262	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—PIK3CA—salivary gland cancer	0.00132	0.00257	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—CREBBP—salivary gland cancer	0.0013	0.00255	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—salivary gland cancer	0.00128	0.00251	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—VCAN—salivary gland cancer	0.00127	0.00249	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.00127	0.00248	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—CREBBP—salivary gland cancer	0.00126	0.00246	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00125	0.00244	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR4—salivary gland cancer	0.0012	0.00236	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—CDH1—salivary gland cancer	0.00118	0.0023	CbGpPWpGaD
Captopril—LTA4H—Metabolism—NUP62—salivary gland cancer	0.00114	0.00224	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.00114	0.00223	CbGpPWpGaD
Captopril—LTA4H—Metabolism—VCAN—salivary gland cancer	0.00113	0.00222	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—PIK3CA—salivary gland cancer	0.00111	0.00217	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—MAP2K2—salivary gland cancer	0.0011	0.00216	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—HRAS—salivary gland cancer	0.0011	0.00215	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00109	0.00214	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00107	0.00209	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00106	0.00208	CbGpPWpGaD
Captopril—F2—Hemostasis—GUCY1A3—salivary gland cancer	0.00104	0.00204	CbGpPWpGaD
Captopril—F2—Hemostasis—GAS6—salivary gland cancer	0.00104	0.00204	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00103	0.00201	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—HRAS—salivary gland cancer	0.00103	0.00201	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00103	0.00201	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ISL1—salivary gland cancer	0.00102	0.00199	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000995	0.00195	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—EP300—salivary gland cancer	0.000978	0.00191	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—salivary gland cancer	0.000955	0.00187	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—MC3R—salivary gland cancer	0.000948	0.00186	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGFBP2—salivary gland cancer	0.000918	0.0018	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—PTEN—salivary gland cancer	0.000898	0.00176	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—PIK3CA—salivary gland cancer	0.000891	0.00174	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—EP300—salivary gland cancer	0.000888	0.00174	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—salivary gland cancer	0.000879	0.00172	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MAP2K2—salivary gland cancer	0.000865	0.00169	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EP300—salivary gland cancer	0.000857	0.00168	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.000846	0.00165	CbGpPWpGaD
Captopril—F2—PAR1-mediated thrombin signaling events—PIK3CA—salivary gland cancer	0.000825	0.00161	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—GAS6—salivary gland cancer	0.000818	0.0016	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.000816	0.0016	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—HRAS—salivary gland cancer	0.000806	0.00158	CbGpPWpGaD
Captopril—ABCB1—lymph node—salivary gland cancer	0.000804	0.00164	CbGeAlD
Captopril—ALB—Platelet activation, signaling and aggregation—GAS6—salivary gland cancer	0.000801	0.00157	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000764	0.0015	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—FOXO3—salivary gland cancer	0.000756	0.00148	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—CDH1—salivary gland cancer	0.000752	0.00147	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—salivary gland cancer	0.000731	0.00143	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—HRAS—salivary gland cancer	0.000719	0.00141	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000711	0.00139	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000709	0.00139	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—salivary gland cancer	0.0007	0.00137	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCND1—salivary gland cancer	0.0007	0.00137	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—FBXW7—salivary gland cancer	0.000692	0.00135	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000678	0.00133	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00066	0.00129	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.000642	0.00126	CbGpPWpGaD
Captopril—ALB—Hemostasis—JMJD1C—salivary gland cancer	0.000641	0.00125	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—salivary gland cancer	0.000636	0.00124	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—PIK3CA—salivary gland cancer	0.000626	0.00122	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—FBXW7—salivary gland cancer	0.000622	0.00122	CbGpPWpGaD
Captopril—F2—Hemostasis—MYB—salivary gland cancer	0.000619	0.00121	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MAP2K2—salivary gland cancer	0.000618	0.00121	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—salivary gland cancer	0.000613	0.0012	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.000608	0.00119	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PTEN—salivary gland cancer	0.000586	0.00115	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MAP2K2—salivary gland cancer	0.000568	0.00111	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—salivary gland cancer	0.000567	0.00111	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000554	0.00108	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000547	0.00107	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—MC3R—salivary gland cancer	0.000536	0.00105	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—HRAS—salivary gland cancer	0.000529	0.00104	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000523	0.00102	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NOTCH1—salivary gland cancer	0.000506	0.00099	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000501	0.000981	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—FOXO3—salivary gland cancer	0.000496	0.000971	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CDH1—salivary gland cancer	0.000493	0.000965	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00049	0.000958	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MC3R—salivary gland cancer	0.000487	0.000952	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000486	0.000951	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—WNT5B—salivary gland cancer	0.000473	0.000925	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—salivary gland cancer	0.000461	0.000902	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CREBBP—salivary gland cancer	0.000459	0.000898	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL17RD—salivary gland cancer	0.000457	0.000894	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CREBBP—salivary gland cancer	0.000443	0.000867	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—PIK3CA—salivary gland cancer	0.000424	0.000829	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAML3—salivary gland cancer	0.000418	0.000817	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000413	0.000809	CbGpPWpGaD
Captopril—ALB—Hemostasis—GAS6—salivary gland cancer	0.000413	0.000808	CbGpPWpGaD
Captopril—ALB—Hemostasis—GUCY1A3—salivary gland cancer	0.000413	0.000808	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAP2K2—salivary gland cancer	0.000405	0.000793	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.000404	0.000791	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000397	0.000777	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—salivary gland cancer	0.000392	0.000767	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000388	0.00076	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000382	0.000748	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MC3R—salivary gland cancer	0.000372	0.000729	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.000369	0.000722	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WNT5B—salivary gland cancer	0.000365	0.000714	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000358	0.000701	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL17RD—salivary gland cancer	0.000353	0.00069	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—FBXW7—salivary gland cancer	0.00035	0.000686	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NOTCH1—salivary gland cancer	0.000332	0.000649	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DTX4—salivary gland cancer	0.000325	0.000637	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAML3—salivary gland cancer	0.000323	0.000631	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTEN—salivary gland cancer	0.000317	0.000619	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EP300—salivary gland cancer	0.000312	0.000611	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.000305	0.000598	CbGpPWpGaD
Captopril—LTA4H—Metabolism—EP300—salivary gland cancer	0.000302	0.000591	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CREBBP—salivary gland cancer	0.000301	0.000589	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—salivary gland cancer	0.0003	0.000586	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000295	0.000577	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MC3R—salivary gland cancer	0.000287	0.000563	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000277	0.000541	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000275	0.000539	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF16—salivary gland cancer	0.000269	0.000527	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.000255	0.000498	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000255	0.000498	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DTX4—salivary gland cancer	0.000251	0.000492	CbGpPWpGaD
Captopril—ALB—Hemostasis—MYB—salivary gland cancer	0.000245	0.00048	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAML2—salivary gland cancer	0.000234	0.000458	CbGpPWpGaD
Captopril—F2—Hemostasis—CREBBP—salivary gland cancer	0.000228	0.000446	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000228	0.000446	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—salivary gland cancer	0.000225	0.00044	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CA—salivary gland cancer	0.000223	0.000437	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000223	0.000436	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000223	0.000436	CbGpPWpGaD
Captopril—ALB—Metabolism—ISYNA1—salivary gland cancer	0.000221	0.000432	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—salivary gland cancer	0.000214	0.000418	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000211	0.000412	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF16—salivary gland cancer	0.000208	0.000407	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—salivary gland cancer	0.000205	0.000401	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000203	0.000397	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000202	0.000395	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JAG1—salivary gland cancer	0.0002	0.000391	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR4—salivary gland cancer	0.000199	0.000389	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000199	0.000389	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—salivary gland cancer	0.000197	0.000385	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FBXW7—salivary gland cancer	0.000196	0.000383	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000193	0.000379	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000182	0.000357	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAML2—salivary gland cancer	0.000181	0.000353	CbGpPWpGaD
Captopril—ALB—Metabolism—MARCKS—salivary gland cancer	0.00018	0.000352	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000177	0.000346	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000176	0.000345	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000173	0.000338	CbGpPWpGaD
Captopril—ALB—Metabolism—PYGB—salivary gland cancer	0.000167	0.000327	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FOXO3—salivary gland cancer	0.000165	0.000323	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000158	0.000309	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—salivary gland cancer	0.000155	0.000304	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAG1—salivary gland cancer	0.000154	0.000302	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR4—salivary gland cancer	0.000154	0.0003	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FBXW7—salivary gland cancer	0.000151	0.000296	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000151	0.000295	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000149	0.000291	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000147	0.000287	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—salivary gland cancer	0.00014	0.000274	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000138	0.00027	CbGpPWpGaD
Captopril—ALB—Metabolism—PHGDH—salivary gland cancer	0.000136	0.000267	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAP2K2—salivary gland cancer	0.000135	0.000264	CbGpPWpGaD
Captopril—ALB—Metabolism—ST3GAL4—salivary gland cancer	0.000131	0.000257	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000128	0.00025	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FOXO3—salivary gland cancer	0.000127	0.000249	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000123	0.000241	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.00012	0.000234	CbGpPWpGaD
Captopril—ALB—Metabolism—AQP1—salivary gland cancer	0.000119	0.000233	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000118	0.00023	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000115	0.000225	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—salivary gland cancer	0.000115	0.000225	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000113	0.00022	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—salivary gland cancer	0.000111	0.000217	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—salivary gland cancer	0.00011	0.000216	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000108	0.000212	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—salivary gland cancer	0.000106	0.000208	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000104	0.000204	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000104	0.000204	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CREBBP—salivary gland cancer	0.0001	0.000196	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AQP1—salivary gland cancer	9.85e-05	0.000193	CbGpPWpGaD
Captopril—ALB—Metabolism—NUP62—salivary gland cancer	9.46e-05	0.000185	CbGpPWpGaD
Captopril—ALB—Metabolism—VCAN—salivary gland cancer	9.38e-05	0.000184	CbGpPWpGaD
Captopril—ALB—Hemostasis—CREBBP—salivary gland cancer	9.04e-05	0.000177	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	8.84e-05	0.000173	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	8.7e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—salivary gland cancer	8.52e-05	0.000167	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	8.42e-05	0.000165	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NUP62—salivary gland cancer	8.29e-05	0.000162	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	8.23e-05	0.000161	CbGpPWpGaD
Captopril—ABCB1—Metabolism—VCAN—salivary gland cancer	8.22e-05	0.000161	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	7.83e-05	0.000153	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NUP62—salivary gland cancer	7.81e-05	0.000153	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—VCAN—salivary gland cancer	7.75e-05	0.000152	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CREBBP—salivary gland cancer	7.73e-05	0.000151	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—salivary gland cancer	7.4e-05	0.000145	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.26e-05	0.000142	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—salivary gland cancer	7.15e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	6.86e-05	0.000134	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—salivary gland cancer	6.82e-05	0.000133	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—salivary gland cancer	6.59e-05	0.000129	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—salivary gland cancer	6.16e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—salivary gland cancer	6.1e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	5.88e-05	0.000115	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—salivary gland cancer	5.72e-05	0.000112	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.61e-05	0.00011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—salivary gland cancer	5.52e-05	0.000108	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—salivary gland cancer	5.26e-05	0.000103	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—salivary gland cancer	5.04e-05	9.87e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—salivary gland cancer	4.88e-05	9.54e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—salivary gland cancer	4.66e-05	9.13e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—salivary gland cancer	4.56e-05	8.92e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—salivary gland cancer	4.41e-05	8.62e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—salivary gland cancer	4.22e-05	8.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.15e-05	8.12e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—salivary gland cancer	3.89e-05	7.62e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—salivary gland cancer	3.77e-05	7.37e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CREBBP—salivary gland cancer	3.67e-05	7.17e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—salivary gland cancer	3.6e-05	7.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CREBBP—salivary gland cancer	3.21e-05	6.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CREBBP—salivary gland cancer	3.03e-05	5.92e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—salivary gland cancer	2.62e-05	5.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—salivary gland cancer	2.5e-05	4.89e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—salivary gland cancer	2.29e-05	4.49e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—salivary gland cancer	2.19e-05	4.28e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—salivary gland cancer	2.16e-05	4.23e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—salivary gland cancer	2.06e-05	4.03e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—salivary gland cancer	1.85e-05	3.61e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—salivary gland cancer	1.62e-05	3.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	1.53e-05	2.98e-05	CbGpPWpGaD
